Coronavirus: EU launches legal action against 10 countries over cancelled flights compensation

The European Commission says too many passengers whose flights were cancelled amid the COVID-19 pandemic have not been refunded on time or have been offered only vouchers, in violation of EU rules.View on euronews

Brexit negotiations to 'intensify' to reach deal

The European Commission confirmed that EU and UK negotiators resumed face-to-face talks on a post-Brexit trade deal on Monday, with both sides insisting that the process must accelerate if they are to reach an agreement by the end of the year.

Miley Cyrus leads lineup for Global Goal: Unite for Our Future concert

Miley Cyrus leads the lineup for Global Citizen and the European Commission's live summit and show 'Global Goal: Unite for Our Future' concert.

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Stocks rise on recovery hopes

U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.

EU close to fast-tracking COVID-19 treatment drug

The head of the European Union's medicines agency, Guido Rasi, has said an initial authorization for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days. Joe Davies reports.

Brexit briefing: 181 days until the end of the transition period

The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process.

Exxon signals 2nd straight quarterly loss

Exxon Mobil signaled it'll suffer its second consecutive quarterly loss. As Fred Katayama reports, its oil and gas producing and refining businesses will report operating losses in the second quarter.

S&P, Nasdaq rally on vaccination hopes

The S&P 500 and Nasdaq closed higher Wednesday to kick off the third quarter as increasing optimism for a safe and effective COVID-19 vaccine eased concerns that another round of business lockdowns was likely. Fred Katayama reports.

Stocks can charge higher: financial planner

Runnymede Capital Management's Andrew Wang says the massive liquidity and government stimulus measures can drive the market higher in the third quarter. But he tells Reuters' Fred Katayama the markets could also encounter some choppiness in the upcoming earnings season.

United triples its August schedule

United Airlines said Wednesday it would add nearly 25,000 domestic and international flights in August, as travel demand hit by the coronavirus outbreak gradually returns. Fred Katayama reports.